银屑病关节炎功能损害评估:重要性与挑战
本综述通过文献检索评估HAQ-DI在银屑病关节炎患者中的价值与挑战,并讨论替代功能损害评估工具。HAQ-DI虽有地板效应、对晚期疾病治疗反应性不足等局限,但在临床试验中广泛应用于银屑病关节炎且通常能区分有效治疗与安慰剂。目前无银屑病关节炎特异性功能评估工具,作者建议临床医生继续使用HAQ-DI并考虑联合多种工具进行全面评估。
要点
- HAQ-DI在银屑病关节炎中已验证,但存在明显地板效应、对晚期疾病治疗反应性不足及低估以皮肤症状为主患者的功能损害等局限。
- HAQ-DI在银屑病关节炎治疗临床试验中广泛使用,通常对有效治疗的变化有反应性,能区分活动性治疗与安慰剂。
- 目前无银屑病关节炎特异性功能评估工具,作者建议临床医生继续使用HAQ-DI并考虑联合多种工具进行全面评估。
核心结论
- HAQ-DI是有价值的评估工具,临床医生应继续在临床试验和实践中使用。
- 由于目前缺乏专门评估银屑病关节炎患者身体功能的工具,临床医生应考虑联合使用多种工具以进行尽可能全面的评估。
研究设计与样本
- 本综述在MEDLINE、BIOSIS Previews、Embase、Derwent Drug File和SciSearch数据库中使用相关术语和关键词进行文献检索,并由作者从个人文库补充参考文献。
主要发现
- HAQ-DI虽在银屑病关节炎中已验证,但存在明显地板效应、对晚期疾病治疗反应性不足以及低估以皮肤症状为主患者身体损害等局限。
- HAQ-DI在银屑病关节炎治疗临床试验中广泛使用,通常对有效治疗的变化有反应性,能区分活动性治疗与安慰剂。
- 其他关注身体损害的通用或关节炎特异性患者报告问卷包括SF-36、EQ-5D、AIMS和RAPID3。
- 目前无银屑病关节炎特异性身体功能评估工具,但包含功能损害相关元素的健康相关生活质量问卷包括PsAQoL、PsAID和VITACORA-19。
- 由于现有身体损害评估工具可能无法反映银屑病关节炎所有方面对患者的影响,可联合使用DLQI等其他健康相关生活质量工具以更全面了解疾病负担。
关键数值与推荐
- HAQ-DI存在明显地板效应,对晚期疾病治疗效应缺乏反应性,并低估以皮肤症状为主患者的身体损害。
- 目前无银屑病关节炎特异性身体功能评估工具。
临床怎么用
- 作者认为,临床医生应继续在临床试验和实践中使用HAQ-DI。
- 作者建议,由于目前缺乏专门评估银屑病关节炎患者身体功能的工具,临床医生应考虑联合使用多种工具以进行尽可能全面的评估。
- 作者提出,可联合使用DLQI等健康相关生活质量工具以更全面了解疾病负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with psoriatic arthritis (PsA) experience substantial physical impairment. This is commonly assessed using the patient-reported Health Assessment Questionnaire-Disability Index (HAQ-DI), which was originally developed in rheumatoid arthritis. The purpose of this review is to examine the value and challenges of using the HAQ-DI in patients with PsA, and to discuss alternative measures of functional impairment in this condition. METHODS: A literature search was performed in the MEDLINE, BIOSIS Previews, Embase, Derwent Drug File, and SciSearch databases using relevant terms and key words. Additional references from personal libraries were identified by the authors. RESULTS: Although validated in PsA, the HAQ-DI has limitations, including marked floor effects, lack of responsiveness to treatment effects in later disease stages, and underestimation of physical impairment in patients whose symptoms are predominantly skin related. Nonetheless, it has been widely used in clinical trials of PsA treatment and is generally responsive to change with effective therapy, discriminating between active and placebo treatments. Other generic or arthritis-specific patient-reported questionnaires with a focus on physical impairment include the Medical Outcomes Study Short Form-36 Health Survey, the EuroQol-5D, the Arthritis Impact Measurement Scales, and the Routine Assessment of Patient Index Data 3. There are currently no PsA-specific instruments to assess physical function, but health-related quality-of-life questionnaires with elements related to functional impairment include the PsA Quality of Life questionnaire, the PsA Impact of Disease questionnaire, and VITACORA-19. As the available measures of physical impairment may not reflect the impact of all aspects of PsA on a patient, additional health-related quality-of-life instruments, such as the Dermatology Life Quality Index, may be used in parallel to obtain a more complete picture of the disease burden. CONCLUSIONS: The HAQ-DI is a valuable assessment tool that clinicians should continue to use in clinical trials and practice. Because instruments to specifically assess physical function in patients with PsA are currently lacking, clinicians should consider using a combination of instruments to conduct the most thorough evaluation possible.
引用
- Mease P, Strand V, Gladman D, et al. Functional impairment measurement in psoriatic arthritis: Importance and challenges. Semin Arthritis Rheum. 2018. PMID: 30029795. doi:10.1016/j.semarthrit.2018.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。